A research team searches for every gene that helps tumors evade immunotherapy
Broad Institute
OCTOBER 11, 2023
As a first step, Manguso set his sights on treatments called PD-1 checkpoint inhibitors, which at the time had shown tremendous promise in clinical trials and would receive their first FDA approval in 2014. Every part of TIDE has been the fruit of collaboration and multidisciplinary team-based science,” Yates said.
Let's personalize your content